Compounds > 3,4-dihydroxyphenylglycolaldehyde
Page last updated: 2024-09-04

3,4-dihydroxyphenylglycolaldehyde and Degenerative Diseases, Central Nervous System

3,4-dihydroxyphenylglycolaldehyde has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burke, WJ; Chung, HD; Franko, M; Johnson, EM; Kristal, BS; Kumar, VB; Lampe, P; Li, SW; Ruggiero, DA; Williams, EA; Zahm, DS1

Reviews

1 review(s) available for 3,4-dihydroxyphenylglycolaldehyde and Degenerative Diseases, Central Nervous System

ArticleYear
Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases.
    Neurotoxicology, 2004, Volume: 25, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; Animals; Apoptosis; Catecholamines; Catechols; Humans; Neurodegenerative Diseases

2004